Use of dexmedetomidine in sustained ventricular tachycardia.
Parent
B A
BA
Munoz
R
R
Shiderly
D
D
Chrysostomou
C
C
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000150:complications; D002648:Child; D020927:Dexmedetomidine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017180:Tachycardia, Ventricular / Q000188:drug therapy* / Q000209:etiology
D058647:Adrenergic alpha-2 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D000889:Anti-Arrhythmia Agents; D020927:Dexmedetomidine